161.9K XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| John Frederick Ek | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 01 Apr 2025 | 16,432 | 248,202 | - | 1.3 | 22,183 | Common Stock |
| Brian McKelligon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. | 23 Mar 2025 | 7,550 | 420,126 | - | 1.7 | 12,835 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.70 per share. | 23 Mar 2025 | 2,310 | 287,210 | - | 1.7 | 3,927 | Common Stock |
| John Frederick Ek | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 3,594 | 264,634 | - | 1.6 | 5,858 | Common Stock |
| Brian McKelligon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 8,257 | 427,676 | - | 1.6 | 13,459 | Common Stock |
| Brian McKelligon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 7,550 | 435,933 | - | 1.6 | 12,307 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 2,310 | 293,114 | - | 1.6 | 3,765 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 3,594 | 289,520 | - | 1.6 | 5,858 | Common Stock |
| Jennifer Kamocsay | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 3,594 | 179,272 | - | 1.6 | 5,858 | Common Stock |
| Jennifer Kamocsay | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 3,851 | 182,866 | - | 1.6 | 6,277 | Common Stock |
| Pascal Bamford | Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 1,283 | 208,975 | - | 1.6 | 2,091 | Common Stock |
| Pascal Bamford | Chief Clinical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 01 Mar 2025 | 2,567 | 206,408 | - | 1.6 | 4,184 | Common Stock |
| John Frederick Ek | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 87,500 | 268,228 | - | 0 | Common Stock | |
| Brian McKelligon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 218,750 | 443,483 | - | 0 | Common Stock | |
| Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 87,500 | 295,424 | - | 0 | Common Stock | |
| Jennifer Kamocsay | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 87,500 | 186,717 | - | 0 | Common Stock | |
| Pascal Bamford | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2024 | 87,500 | 210,258 | - | 0 | Common Stock | |
| Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 44,959 | 44,959 | - | - | Stock Option (right to buy) | |
| Pascal Bamford | Chief Clinical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 40,000 | 122,758 | - | 0 | Common Stock | |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 11 Jun 2024 | 7,500 | 232,233 | - | 0.3 | 2,273 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2024 | 7,500 | 275,629 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.08 per share. | 11 Jun 2024 | 7,500 | 224,733 | - | 2.1 | 15,630 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2024 | 7,500 | 283,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.01 per share. | 06 Jun 2024 | 7,500 | 224,733 | - | 2.0 | 15,064 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 06 Jun 2024 | 7,500 | 232,233 | - | 0.3 | 2,273 | Common Stock |
| Thomas P. Schnettler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Myla P. Lai-Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Robert G. Shepler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| John Frederick Ek | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.56 per share. | 01 Apr 2024 | 14,272 | 180,728 | - | 4.6 | 65,080 | Common Stock |
| Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 23 Mar 2024 | 2,006 | 101,500 | - | 4.8 | 9,609 | Common Stock |
| Brian McKelligon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 23 Mar 2024 | 7,135 | 224,733 | - | 4.8 | 34,177 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.79 per share. | 23 Mar 2024 | 2,006 | 207,924 | - | 4.8 | 9,609 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 20 Mar 2024 | 7,500 | 239,368 | - | 0.3 | 2,273 | Common Stock |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.97 per share. | 20 Mar 2024 | 7,500 | 231,868 | - | 5.0 | 37,243 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 7,500 | 290,629 | - | - | Employee Stock Option (Right to Buy) | |
| Robert G. Shepler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Mar 2024 | 369,592 | 369,592 | - | 0 | Common Stock | |
| Robert G. Shepler | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Mar 2024 | 369,592 | 0 | - | 0 | Common Stock | |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.94 per share. | 13 Mar 2024 | 7,500 | 224,368 | - | 4.9 | 37,035 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 13 Mar 2024 | 7,500 | 239,368 | - | 0.3 | 2,273 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2024 | 7,500 | 298,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.94 per share. | 13 Mar 2024 | 7,500 | 231,868 | - | 4.9 | 37,043 | Common Stock |
| Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 105,555 | - | 0 | Common Stock | |
| Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 2,049 | 103,506 | - | 6.0 | 12,355 | Common Stock |
| John Frederick Ek | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 195,000 | - | 0 | Common Stock | |
| John Frederick Ek | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 175,000 | 175,000 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 87,500 | 240,063 | - | 0 | Common Stock | |
| Brian McKelligon | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 8,195 | 231,868 | - | 6.0 | 49,416 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 212,235 | - | 0 | Common Stock | |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 2,305 | 209,930 | - | 6.0 | 13,899 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kamocsay | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 35,000 | 102,500 | - | 0 | Common Stock | |
| Jennifer Kamocsay | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 70,000 | 70,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kamocsay | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.03 per share. | 22 Feb 2024 | 3,283 | 99,217 | - | 6.0 | 19,796 | Common Stock |
| McKelligon Brian | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.48 per share. | 19 Dec 2023 | 7,500 | 152,563 | - | 4.5 | 33,566 | Common Stock |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 19 Dec 2023 | 7,500 | 160,063 | - | 0.3 | 2,273 | Common Stock |
| McKelligon Brian | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 7,500 | 305,629 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 12 Dec 2023 | 7,500 | 160,063 | - | 0.3 | 2,273 | Common Stock |
| McKelligon Brian | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 7,500 | 313,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.25 per share. | 12 Dec 2023 | 7,500 | 152,563 | - | 4.2 | 31,871 | Common Stock |
| Myla P. Lai-Goldman | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 20,000 | - | 5 | 100,000 | Common Stock |
| Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 28,500 | - | 5 | 100,000 | Common Stock |
| Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 234,592 | - | 5 | 100,000 | Common Stock |
| Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 1,803,373 | 15,937,535 | - | 5 | 9,016,865 | Common Stock |
| Thomas A. Raffin | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 196,627 | 1,737,712 | - | 5 | 983,135 | Common Stock |
| Robert G. Shepler | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 120,000 | 369,592 | - | 5 | 600,000 | Common Stock |
| Matthew Winkler | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 203,388 | 984,513 | - | 5 | 1,016,940 | Common Stock |
| John Frederick Ek | CFO | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 12 Jun 2023 | 20,000 | 20,000 | - | 5 | 100,000 | Common Stock |
| Brian McKelligon | Director, President/CEO | Sale of securities on an exchange or to another person at price $ 5.71 per share. | 06 Jun 2023 | 5,000 | 152,563 | - | 5.7 | 28,537 | Common Stock |
| Brian McKelligon | Director, President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 5,000 | 328,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 06 Jun 2023 | 5,000 | 157,563 | - | 0.3 | 1,515 | Common Stock |
| Thomas P. Schnettler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Myla P. Lai-Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Robert G. Shepler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 56,322 | 56,322 | - | - | Stock Option (Right to Buy) | |
| Frederic Pla | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 23 Mar 2023 | 1,945 | 40,555 | - | 7.7 | 14,957 | Common Stock |
| Brian McKelligon | Director, President/CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 23 Mar 2023 | 7,437 | 152,563 | - | 7.7 | 57,191 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.69 per share. | 23 Mar 2023 | 1,945 | 177,235 | - | 7.7 | 14,957 | Common Stock |
| John Frederick Ek | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 160,000 | 160,000 | - | 0 | Common Stock | |
| John Frederick Ek | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 160,000 | 160,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kamocsay | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 75,000 | 75,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kamocsay | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 37,500 | 37,500 | - | 0 | Common Stock | |
| Brian McKelligon | Director, President/CEO | Sale of securities on an exchange or to another person at price $ 9.13 per share. | 14 Mar 2023 | 4,774 | 160,226 | - | 9.1 | 43,610 | Common Stock |
| Brian McKelligon | Director, President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2023 | 5,000 | 333,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | Director, President/CEO | Sale of securities on an exchange or to another person at price $ 9.92 per share. | 14 Mar 2023 | 226 | 160,000 | - | 9.9 | 2,241 | Common Stock |
| Brian McKelligon | Director, President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 14 Mar 2023 | 5,000 | 165,000 | - | 0.3 | 1,515 | Common Stock |
| Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Frederic Pla | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 42,500 | - | 0 | Common Stock | |
| Brian McKelligon | President/CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 160,000 | 160,000 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | President/CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 80,000 | 160,000 | - | 0 | Common Stock | |
| Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 45,000 | 45,000 | - | - | Employee Stock Option (Right to Buy) | |
| Niro Ramachandran | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 22,500 | 179,180 | - | 0 | Common Stock | |
| Marilee Moy | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 20,000 | 20,000 | - | 0 | Common Stock | |
| Marilee Moy | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 40,000 | 40,000 | - | - | Employee Stock Option (Right to Buy) | |
| Ehab El-Gabry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 32,500 | 32,500 | - | - | Employee Stock Option (Right to Buy) | |
| Ehab El-Gabry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 16,250 | 16,250 | - | 0 | Common Stock | |
| Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 34,000 | 62,566 | - | - | Employee Stock Option (Right to Buy) | |
| Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 15 Feb 2023 | 34,000 | 156,680 | - | 0.9 | 30,940 | Common Stock |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2022 | 250,000 | 110,958 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 22 Dec 2022 | 250,000 | 262,500 | - | 0.4 | 110,000 | Common Stock |
| Joseph Driscoll | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 14 Dec 2022 | 10,039 | 12,500 | - | 12.7 | 127,187 | Common Stock |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 14 Dec 2022 | 14,574 | 27,074 | - | 0.4 | 6,413 | Common Stock |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.44 per share. | 14 Dec 2022 | 10,039 | 22,539 | - | 0.4 | 4,417 | Common Stock |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 14,574 | 108,712 | - | - | Employee Stock Option (Right to Buy | |
| Joseph Driscoll | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2022 | 10,039 | 123,466 | - | - | Employee Stock Option (Right to Buy) | |
| Joseph Driscoll | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.45 per share. | 14 Dec 2022 | 14,574 | 12,500 | - | 12.5 | 181,519 | Common Stock |
| Thomas P. Schnettler | Director | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 13 Dec 2022 | 71,050 | 2,742,721 | - | 13.0 | 925,782 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 13 Dec 2022 | 100 | 555,084 | - | 13.3 | 1,325 | Common Stock |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 06 Dec 2022 | 5,000 | 85,000 | - | 0.3 | 1,515 | Common Stock |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2022 | 5,000 | 338,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | President/CEO | Sale of securities on an exchange or to another person at price $ 12.08 per share. | 06 Dec 2022 | 5,000 | 80,000 | - | 12.1 | 60,415 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 02 Dec 2022 | 1,100 | 591,978 | - | 13.3 | 14,575 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.36 per share. | 01 Dec 2022 | 5,000 | 593,078 | - | 13.4 | 66,788 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 16 Nov 2022 | 300 | 598,078 | - | 13.3 | 3,976 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.31 per share. | 10 Nov 2022 | 3,810 | 618,978 | - | 13.3 | 50,705 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 10 Nov 2022 | 600 | 598,378 | - | 13.3 | 7,966 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.29 per share. | 10 Nov 2022 | 20,000 | 598,978 | - | 13.3 | 265,858 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.26 per share. | 14 Sep 2022 | 8,305 | 622,788 | - | 13.3 | 110,084 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.30 per share. | 09 Sep 2022 | 1,800 | 631,093 | - | 13.3 | 23,944 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.31 per share. | 09 Sep 2022 | 22,191 | 632,893 | - | 13.3 | 295,338 | Common Stock |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 07 Sep 2022 | 5,000 | 85,000 | - | 0.3 | 1,515 | Common Stock |
| Brian McKelligon | President/CEO | Sale of securities on an exchange or to another person at price $ 12.83 per share. | 07 Sep 2022 | 5,000 | 80,000 | - | 12.8 | 64,170 | Common Stock |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Sep 2022 | 5,000 | 343,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | President/CEO | Sale of securities on an exchange or to another person at price $ 10.25 per share. | 15 Jun 2022 | 5,000 | 80,000 | - | 10.3 | 51,260 | Common Stock |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 348,129 | - | - | Employee Stock Option (Right to Buy) | |
| Brian McKelligon | President/CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.30 per share. | 15 Jun 2022 | 5,000 | 85,000 | - | 0.3 | 1,515 | Common Stock |
| Thomas P. Schnettler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Myla P. Lai-Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Thomas A. Raffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Robert G. Shepler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 30,549 | 30,549 | - | - | Stock Option (Right to Buy | |
| Ehab El-Gabry | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.91 per share. | 13 Apr 2022 | 75,107 | 122,680 | - | 0.9 | 68,347 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2022 | 75,107 | 96,566 | - | - | Employee Stock Option (Right to Buy) | |
| Marilee Moy | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2022 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 13.25 per share. | 13 Dec 2021 | 100 | 555,084 | - | 13.3 | 1,325 | Common Stock |
| Garry Nolan | Director | Sale of securities on an exchange or to another person at price $ 12.67 per share. | 09 Dec 2021 | 25,000 | 655,084 | - | 12.7 | 316,763 | Common Stock |
| Scott Mendel | Director | Purchase of securities on an exchange or from another person at price $ 13.16 per share. | 19 Nov 2021 | 8,500 | 8,500 | - | 13.2 | 111,860 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 13.13 per share. | 19 Nov 2021 | 25,000 | 25,073 | - | 13.1 | 328,293 | Common Stock |
| Niro Ramachandran | Chief Business Officer | Purchase of securities on an exchange or from another person at price $ 12.85 per share. | 19 Nov 2021 | 73 | 73 | - | 12.8 | 938 | Common Stock |
| Robert G. Shepler | Director | Purchase of securities on an exchange or from another person at price $ 12.92 per share. | 18 Nov 2021 | 20,000 | 35,000 | - | 12.9 | 258,500 | Common Stock |
| Robert G. Shepler | Director | Purchase of securities on an exchange or from another person at price $ 12.17 per share. | 18 Nov 2021 | 15,000 | 15,000 | - | 12.2 | 182,505 | Common Stock |
| Myla P. Lai-Goldman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 38,993 | 38,993 | - | - | Stock Option (Right to Buy | |
| Scott Mendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 35,562 | 35,562 | - | - | Stock Option (Right to Buy | |
| Thomas P. Schnettler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy | |
| Robert G. Shepler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy | |
| Matthew Winkler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy | |
| Garry Nolan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 16,860 | 16,860 | - | - | Stock Option (Right to Buy |